Article
Eyetech, Archemix join forces on aptamer research
Eyetech Pharmaceuticals and Archemix Corp. agreed to collaborate on the research and development of aptamers to develop for use in the treatment of ophthalmic diseases.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
